Table 2.
Gene-based pharmacoepigenetic studies of antidepressants in rodents
Gene | Epigenetic Mark | Baseline or Post-treatment | Antidepressant | Species/strain, model | Tissue | Outcome | Reference |
---|---|---|---|---|---|---|---|
Bdnf | 5mC within promoter IV | Post-treatment | Fluoxetine | C57BL/6 J mice, post-stroke depression model | Hippocampus | ↑5mC in 2 CpG sites ↑ Bdnf expression ↓ depression-like behaviors |
Jin et al. (2017) |
H4K12ac within promoter III | Post-treatment | Fluoxetine + HDAC inhibitor | Balb/c mice, infant maternal separation | Forebrain neocortex | ↑ H4K12ac ↑ Bdnf expression ↓ depression-like behaviors |
Schmauss (2015) | |
H3ac within promoter III and IV | Post-treatment | Imipramine | Adult male Bl6/C57 mice, chronic social stress model | Hippocampus | ↑ H3ac within promoters III and VI ↑ Bdnf IV expression |
Tsankova et al. (2006) | |
H3K9me2 downstream of exon IV | Post-treatment | Tranylcypromine | C57BL/6J mice, social stress model | mPFC | ↓ H3K9me2 ↑ Bdnf IV expression reversed cognitive inflexibility of social stress |
Xu et al. (2018) | |
5mC within promoter | Post-treatment | Genipin | PRS mice (offspring of prenatally stressed dams) | Hippocampus | 5mC demethylation through inhibition of DNMT1 normalized Bdnf expression reversed depressive-like behaviors |
Ye et al. (2018) | |
- | Post-treatment | SAHA | Crtc1(-/) mice | PFC | ↑ Bdnf IV expression partially rescued depressive-like behavior |
Meylan et al. (2016) | |
Htr1a | 5mC within promoter |
Post-treatment | Imipramine | Adult male BALB/c Mice exposed to unpredictable chronic mild stress | PFC, midbrain | ↓ 5mC of 1 CpG reversed depressive-like phenotype |
Le Francois et al. (2015) |
S100a10 | 5mC within promoter | Post-treatment | Escitalopram | Female FSL rodent model of depression | PFC | ↓ 5mC ↑ S100a10 expression |
Melas et al. (2012) |
Crf | 5mC within promoter | Post-treatment | Imipramine | Adult mice exposed to social defeat | Hypothalamus | ↑ 5mC at 5 CpGs ↓ Crf expression ↓ social avoidance behavior |
Elliott et al. (2010) |
Nr2b | H3K9ac and H3K27ac within promoter | Post-treatment | Imipramine | Mouse fetuses | Neocortical neurons | ↑ H3ac ↑ Nrb2 expression ↓ HDAC3 and HDAC4 activity |
Nghia et al. (2015) |
Grm2 | H3K27ac within promoter | Post-treatment | LAC | FSL rodent model of depression | Hippocampus, PFC | ↑ H3K27ac ↑ Grm2 expression |
Nasca et al. (2013) |
Abbreviations: 5mC – 5-methylcytosine; Bdnf – brain-derived neurotrophic factor; Crf – corticotrophin-releasing factor; FSL – Flinders Sensitive Line; Grm2 – glutamate metabotropic receptor type; H3ac – histone 3 acetylation; H3K9me2 – histone 3 lysine 9 dimethylation; H4K12ac – histone 4 lysine 12 acetylation; H3K9ac – histone 3 lysine 9 acetylation; HDAC – histone deacetylase; Htr1a – 5-Hydroxytryptamine receptor 1A; LAC – L-acetylcarnitine; Nr2b – N-methyl D-aspartate receptor subtype 2B; PFC – prefrontal cortex; S100a10 – S100 Calcium Binding Protein A10; SAHA – suberoylanilide hydroxamic acid.